OBJECTIVES: Microbial-specific factors are likely critical in determining whether bacteria trigger preterm labor. Structural variations in lipopolysaccharide (LPS), a component of gram-negative bacteria, can determine whether LPS has an inflammatory (agonist) or anti-inflammatory (antagonist) effect through Toll-like receptor 4 (TLR4). Our objective was to determine whether amniochorion could discriminate between LPS variants in a nonhuman primate model. We also cloned Macaca nemestrina TLR4 and MD-2 and compared this complex functionally to the human homologue to establish whether nonhuman primates could be used to study TLR4 signaling in preterm birth. STUDY DESIGN: Amniochorion explants from M. nemestrina were stimulated with a panel of LPS variants for 24 h. Supernatants were analyzed for IL-1beta, TNF-alpha, IL-6, IL-8 and prostaglandins E2 and F2alpha. Tissue expression of TLR1, 2, 4, 6, MyD88 and NF-kappaB was studied by RT-PCR. M. nemestrina TLR4 and MD-2 genes were cloned and compared with their human counterparts in a recombinant TLR4 signaling system to determine LPS sensitivity. RESULTS: LPS variants differentially stimulated cytokines and prostaglandins, which was not related to transcriptional changes of TLR4 or other TLRs. Nearly all elements of LPS binding and TLR4 leucine-rich repeats were conserved between humans and M. nemestrina. TLR4/MD-2 signaling complexes from both species were equally sensitive to LPS variants. CONCLUSIONS: LPS variants elicit a hierarchical inflammatory response within amniochorion that may contribute to preterm birth. LPS sensitivity is similar between M. nemestrina and humans, validating M. nemestrina as an appropriate model to study TLR4 signaling in preterm birth. Copyright 2010 Elsevier Ltd. All rights reserved.
OBJECTIVES: Microbial-specific factors are likely critical in determining whether bacteria trigger preterm labor. Structural variations in lipopolysaccharide (LPS), a component of gram-negative bacteria, can determine whether LPS has an inflammatory (agonist) or anti-inflammatory (antagonist) effect through Toll-like receptor 4 (TLR4). Our objective was to determine whether amniochorion could discriminate between LPS variants in a nonhuman primate model. We also cloned Macaca nemestrinaTLR4 and MD-2 and compared this complex functionally to the human homologue to establish whether nonhuman primates could be used to study TLR4 signaling in preterm birth. STUDY DESIGN: Amniochorion explants from M. nemestrina were stimulated with a panel of LPS variants for 24 h. Supernatants were analyzed for IL-1beta, TNF-alpha, IL-6, IL-8 and prostaglandins E2 and F2alpha. Tissue expression of TLR1, 2, 4, 6, MyD88 and NF-kappaB was studied by RT-PCR. M. nemestrinaTLR4 and MD-2 genes were cloned and compared with their human counterparts in a recombinant TLR4 signaling system to determine LPS sensitivity. RESULTS:LPS variants differentially stimulated cytokines and prostaglandins, which was not related to transcriptional changes of TLR4 or other TLRs. Nearly all elements of LPS binding and TLR4 leucine-rich repeats were conserved between humans and M. nemestrina. TLR4/MD-2 signaling complexes from both species were equally sensitive to LPS variants. CONCLUSIONS:LPS variants elicit a hierarchical inflammatory response within amniochorion that may contribute to preterm birth. LPS sensitivity is similar between M. nemestrina and humans, validating M. nemestrina as an appropriate model to study TLR4 signaling in preterm birth. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: Jie Fan; Andras Kapus; Philip A Marsden; Yue Hua Li; George Oreopoulos; John C Marshall; Stefan Frantz; Ralph A Kelly; Ruslan Medzhitov; Ori D Rotstein Journal: J Immunol Date: 2002-05-15 Impact factor: 5.422
Authors: Gary Leveque; Vincenzo Forgetta; Shaun Morroll; Adrian L Smith; Nat Bumstead; Paul Barrow; J C Loredo-Osti; Kenneth Morgan; Danielle Malo Journal: Infect Immun Date: 2003-03 Impact factor: 3.441
Authors: Bryan S Michalowicz; James S Hodges; Anthony J DiAngelis; Virginia R Lupo; M John Novak; James E Ferguson; William Buchanan; James Bofill; Panos N Papapanou; Dennis A Mitchell; Stephen Matseoane; Pat A Tschida Journal: N Engl J Med Date: 2006-11-02 Impact factor: 91.245
Authors: Stephen R Coats; Jace W Jones; Christopher T Do; Pamela H Braham; Brian W Bainbridge; Thao T To; David R Goodlett; Robert K Ernst; Richard P Darveau Journal: Cell Microbiol Date: 2009-06-13 Impact factor: 3.715
Authors: Mohak V Mhatre; Julie A Potter; Charles J Lockwood; Graciela Krikun; Vikki M Abrahams Journal: Am J Reprod Immunol Date: 2016-04-24 Impact factor: 3.886
Authors: Kristina M Adams Waldorf; Natasha Singh; Aarthi R Mohan; Roger C Young; Lisa Ngo; Ananya Das; Jesse Tsai; Aasthaa Bansal; Louis Paolella; Bronwen R Herbert; Suren R Sooranna; G Michael Gough; Cliff Astley; Keith Vogel; Audrey E Baldessari; Theodor K Bammler; James MacDonald; Michael G Gravett; Lakshmi Rajagopal; Mark R Johnson Journal: Am J Obstet Gynecol Date: 2015-08-15 Impact factor: 8.661
Authors: Mai Hoang; Julie A Potter; Stefan M Gysler; Christina S Han; Seth Guller; Errol R Norwitz; Vikki M Abrahams Journal: Biol Reprod Date: 2014-02-27 Impact factor: 4.285
Authors: Ryan M McAdams; Jeroen Vanderhoeven; Richard P Beyer; Theo K Bammler; Federico M Farin; H Denny Liggitt; Raj P Kapur; Michael G Gravett; Craig E Rubens; Kristina M Adams Waldorf Journal: PLoS One Date: 2012-10-09 Impact factor: 3.240
Authors: Jeroen P Vanderhoeven; Craig J Bierle; Raj P Kapur; Ryan M McAdams; Richard P Beyer; Theo K Bammler; Federico M Farin; Aasthaa Bansal; Min Spencer; Mei Deng; Michael G Gravett; Craig E Rubens; Lakshmi Rajagopal; Kristina M Adams Waldorf Journal: PLoS Pathog Date: 2014-03-06 Impact factor: 6.823